期刊文献+

胃癌综合治疗临床疗效分析 被引量:9

The Clinical Analyses of Therapeutic Effect of Comprehensive Therapy on Gastric Carcinoma
下载PDF
导出
摘要 目的探讨胃癌患者综合治疗的临床疗效。方法回顾性分析收治的220例胃癌手术患者的临床资料。针对TNM分期采用相应的治疗方案,比较不同治疗组的R0切除率、术后2年复发率及死亡率。结果Ⅰ期患者均R0切除,无复发、死亡病例;Ⅱ期患者均R0切除,复发率为18.8%,死亡率为12.5%。Ⅲ、Ⅳ期新辅助化疗(NAC)组和常规化疗(CC)组R0切除率分别为73.8%、61.2%,比较差异有统计学意义(P<0.05);复发率分别为38.5%、46.3%,比较差异有统计学意义(P<0.05);死亡率分别为32.3%、34.3%,比较差异无统计学意义(P>0.05)。结论早期胃癌疗效好,实施胃癌缩小根治术安全有效;NAC能提高进展期胃癌R0切除率,降低术后复发率;合理施行以手术为主的综合治疗有助于改善胃癌预后。 Objective To observe the effect of comprehensive therapy on the patients with gastric carcinoma.Methods The prognostic factors of gastric carcinoma were analyzed based on clinical data of 220 cases with gastric carcinoma who underwent surgical treatment.The rates of curative resection,recurrence,and mortality were analyzed between the different stages which were parted by the method of TNM.Results The stage I gastric carcinomas were all radical resected and found no recurrence or died case;the rates of curative resection,recurrence,and mortality of the stage Ⅱ patients were 100.0%,18.8% and 12.5% respectively;the rates of curative resection,recurrence,and mortality of the new adjuvant chemotherpy(NAC)group and the common chemocherapy(CC) group were(73.8% vs 61.2%,P0.05),(38.5% vs 46.3%,P0.05),and(32.3% vs 34.3%,P0.05) respectively.Conclusion A suitable small resection operation for early gastric carcinoma is efficient and its prognoses are very good.NAC for the advanced gastric carcinoma is effective,which can improve the rate of curative resection and reduce the postoperative recurrence.Surgery-based comprehensive therapy used individually will improve the therapeutic effect of gastric carcinoma.
出处 《肿瘤基础与临床》 2011年第2期146-148,共3页 journal of basic and clinical oncology
关键词 早期胃癌 进展期胃癌 新辅助化疗 综合治疗 early gastric carcinoma advanced gastric carcinoma new adjuvant chemotherapy comprehensive therapy
  • 相关文献

参考文献7

  • 1詹文华.胃癌多学科综合治疗模式[J].中国实用外科杂志,2009,29(9):722-726. 被引量:9
  • 2陈峻青.胃癌外科治疗的术式选择与评价[J].中华医学杂志,2004,84(24):2057-2059. 被引量:51
  • 3Shimoyama S,Seto Y,Yasuda H,et al.Concepts,rationale,and current outcomes of less invasive gurgical strategies for early gastric cancer:data from a quarter-century of experience in a single institution[J].World J Surg,2005,29(1):58-65.
  • 4季加孚.进展期胃癌外科治疗模式的转换[J].中华医学杂志,2005,85(30):2091-2093. 被引量:11
  • 5De Vita F,Giuliani F,Galizia G,et al.Neo-adjuvant and adjuvant chemotherapy of gastric cancer[J].Ann Oncol,2007,18(Suppl 6):120-123.
  • 6Sakuramoto S,Sasako M,Yamaguchi T,et al.Adjuvant chemothempy for gastric cancer with S-1,an oral fluoropyrimidine[J].N ErIgl J Med,2007,357(18):1810-1820.
  • 7Mansour JC,Tang L,Shah M,et al.Does graded histoiogic response after neoadjuvant chemotherapy predict survival for completely reseeted gastric cancer[J].Ann Surg Oncol,2007,14(12):3412-3418.

二级参考文献30

  • 1陈峻青,王舒宝,齐春莲,单吉贤,徐惠绵,刘庆华,张文范,张荫昌.对胃癌手术中不同淋巴结清除术的合理评价[J].中华医学杂志,1995,75(2):110-113. 被引量:33
  • 2Verdecchia A, Corazziari I, Gatta G, et al. Explaining gastric cancer survival differences among European countries [J]. Int J Cancer, 2004, 109(5):737-741.
  • 3Macintyre IMC, Akoh JA. Improving survival in gastric cancer: review of operative mortality in English language publications from 1970[J]. ar J Surg,1991,78(7):771-776.
  • 4Akoh JA, Macintyre IM. Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970[J]. BrJ Surg, 1992,79(4):293-299.
  • 5Wu CW, Hsiung CA, Lo SS, et al. Nodal dissection for patients with gastric cancer: A randomized controlled trial [J]. Lancet Oncol, 2006,7(4):309-315.
  • 6Sasako M, Takeshi S, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer[J]. N Engl J Med, 2008,359 (5) :453-462.
  • 7Moertel C, Childs D, Reitemeier R, et al. Combinded 5-fluorouracil and supervohagr radiation therapy for locally unresectable gastriointestinal cancer[J ]. Lancet, 1969,2(7626):865-867.
  • 8Zhang ZX, Gu XZ, Yin WB, et al. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of the gasyric cardia(AGC)-report on 370 patients [J]. Int J Radiat Oncol Biol Phys, 1998,42(5): 929-934.
  • 9Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy venus surgery alone for resectable gastroesophageal cancer[J]. N Engl J Med, 2006,355(1):11-20.
  • 10Nashimoto A, Nakajima T, Furukawa H, et al. Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral flurouracil in serosa-negative gastric cancer: Japan clinical oneology group 9206-1 [J]. J Clin Oncol,2003,21(12):2282-2287.

共引文献66

同被引文献74

引证文献9

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部